KURA
Kura Oncology, Inc.
stockNASDAQ
at kura oncology, we are committed to realizing the promise of precision medicines for cancer. the genomics revolution is transforming how we treat cancer. we now understand that how a patient responds to treatment depends in part on the genetic makeup of the cancer and, importantly, we have the knowledge and tools to create targeted treatments and companion diagnostics to identify those patients most likely to benefit. this new era offers the potential for innovative treatments that are safer and more effective for patients with particular cancers. we are leveraging our insights into cancer genetics as well as our core strength of translating novel science into life-saving medicines to advance a pipeline of precision medicines. our development programs target cancers with high unmet need, including lung, colorectal, thyroid and pancreatic cancers as well as blood cancers such as lymphoma and leukemias. our goal is to help patients with cancer lead better, longer lives.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 10.61 | 2026-09-28 | -2.64% | -0.530 |
| 1M | 13.25 | 2026-09-04 | -22.04% | 1.859 |
| 3M | 11.04 | 2026-07-06 | -6.43% | 1.288 |
| 6M | 8.49 | 2026-04-06 | +21.67% | 1.193 |
| 1Y | 9.80 | 2025-10-06 | +5.41% | 1.400 |
| 2Y | 18.04 | 2024-10-04 | -42.74% | — |
| 5Y | 18.73 | 2021-10-05 | -44.85% | 1.077 |
Kura Oncology, Inc. (NASDAQ:KURA) stock price today is $10.33, and today's volume is 266,713. KURA is down 3.005% today. The 30 day average volume is 2.04M. KURA market cap is $918.96M with 88.96M shares outstanding.